Pascal Wolter

机构：KU Leuven

发表论文 164 篇 · 总被引 8680 次 · h-index 37

代表论文

• Response to brentuximab vedotin versus physician’s choice by CD30 expression and large cell transformation status in patients with mycosis fungoides: An ALCANZA sub-analysis (2021 · European Journal of Cancer · 被引 59)
• Tailored immunotherapy approach with nivolumab with or without nivolumab plus ipilimumab as immunotherapeutic boost in patients with metastatic renal cell carcinoma (TITAN-RCC): a multicentre, single-arm, phase 2 trial (2023 · The Lancet Oncology · 被引 36)
• Patient-reported quality of life in patients with relapsed/refractory cutaneous T-cell lymphoma: Results from the randomised phase III ALCANZA study (2020 · European Journal of Cancer · 被引 31)
• Dabrafenib plus trametinib in BRAF K601E‐mutant melanoma (2018 · British Journal of Dermatology · 被引 17)
• Quantitative Whole-Body Diffusion-weighted MRI after One Treatment Cycle for Aggressive Non-Hodgkin Lymphoma Is an Independent Prognostic Factor of Outcome (2021 · Radiology Imaging Cancer · 被引 6)
• Fibroblast Growth Factor Receptor-2 Polymorphism rs2981582 is Correlated With Progression-free Survival and Overall Survival in Patients With Metastatic Clear-cell Renal Cell Carcinoma Treated With Sunitinib (2018 · Clinical Genitourinary Cancer · 被引 4)